Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Shares Outstanding (Weighted Average) (2016 - 2018)

Historic Shares Outstanding (Weighted Average) for Select Medical Holdings (SEM) over the last 4 years, with Q3 2018 value amounting to $130.4 million.

  • Select Medical Holdings' Shares Outstanding (Weighted Average) rose 96.41% to $130.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $130.4 million, marking a year-over-year increase of 96.41%. This contributed to the annual value of $129.0 million for FY2017, which is 89.35% up from last year.
  • According to the latest figures from Q3 2018, Select Medical Holdings' Shares Outstanding (Weighted Average) is $130.4 million, which was up 96.41% from $129.8 million recorded in Q2 2018.
  • Select Medical Holdings' Shares Outstanding (Weighted Average)'s 5-year high stood at $130.4 million during Q3 2018, with a 5-year trough of $127.5 million in Q4 2015.
  • In the last 4 years, Select Medical Holdings' Shares Outstanding (Weighted Average) had a median value of $129.0 million in 2017 and averaged $128.9 million.
  • Per our database at Business Quant, Select Medical Holdings' Shares Outstanding (Weighted Average) rose by 26.28% in 2016 and then skyrocketed by 96.41% in 2018.
  • Over the past 4 years, Select Medical Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $127.5 million in 2015, then grew by 0.26% to $127.8 million in 2016, then rose by 0.89% to $129.0 million in 2017, then grew by 1.11% to $130.4 million in 2018.
  • Its Shares Outstanding (Weighted Average) was $130.4 million in Q3 2018, compared to $129.8 million in Q2 2018 and $129.7 million in Q1 2018.